Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Hamps Bio Ltd (NSE: HAMPS), ISIN INE0QBD01018 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
HAMPS last traded at ₹22.99 (+9.63%), with a 52-week range of ₹13.36 to ₹26.58 (as of 23 Sep 2026).
Shareholding as of Sep 2025: promoters 71.99%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 70/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.